Nyenta.com

Menu
  • Home
  • Business
  • Books
  • Entertainment
  • Financial
  • Music
  • Banking
  • Health
  • Technology
Menu

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SRPT
Nyenta.com/10232694

Trending...
  • SVB DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In SVB To Contact Him Directly To Discuss Their Options
  • The Magic School Bus: Lost In The Solar System Live At Tribeca PAC
  • COINBASE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Coinbase To Contact Him Directly To Discuss Their Options
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Sarepta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=1306 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On March 16, 2023, after market hours, the Company issued a press release which "announced that at its late cycle meeting for the SRP-9001 (delandistrogene moxeparvovec) biologics license application (BLA), the U.S. Food and Drug Administration's Office of Therapeutics (OTP) has determined that an advisory committee meeting will be held for SRP-9001 in advance of the May 29, 2023 regulatory action date."

More on Nyenta.com
  • Where to Commission a Custom 1/6 Head Sculpt?
  • Shima Capital's Founder Yida Gao Teaches Crypto Finance Course at MIT
  • Max Amini Announces Powerful Interview with Reza Pahlavi, Former Crown Prince of Iran; to Premiere April 1st
  • Trump Bus rolls into Georgia Ron DeSantis event overshadowing Tiny Desantis box truck at Veterans for Trump lead mini-rally
  • Palos Verdes Real Estate Agent Promotes Homes To MORE Opportune Buyers For Significantly MORE Money

On this news, the price of Sarepta's stock fell sharply during after-hours trading on March 16, 2023.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

More on Nyenta.com
  • Moore Kuehn Encourages DFFN, KMF, CSTI, and BGRY Investors to Contact Law Firm
  • Access Control Systems Expands and Rebrands as Guardian Access Solutions as Part of Increased Service Offerings
  • Peachtree Immediate Care Opens Urgent Care Clinic in Marietta
  • Olga Torres Named Top Advisor by Foreign Investment Watch
  • Attorney Steve Hilst Named Partner at Bisnar Chase

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Nyenta.com
  • Sherry Orel Joins STS Capital Partners
  • American Equus Expands Product Line with Suomy Riding Helmets
  • Lewy Body Dementia Resource Center Introduces a New Video Production
  • Arbutus Medical Launches TrakPak® with QuikBow™ to Improve Skeletal Traction, Announces Successful Cases
  • Waterleaf International, LLC Announces Hiring of Chief Sales Officer
  • Experimental Detachment: Why Avant-Garde Fashion Is Starting to Feel Tone-Deaf
  • EVERWILD Returns To Legend Valley With Lineup Featuring Pepper, Bone Thugs-N-Harmony, and host band Tropidelic
  • World's First AI-Generated Satirical News Website Launches, Outperforms Humans in Humor and Intelligence
  • Kookalimba Launches KooKalimba 17 keys Acrylic Kalimba
  • Fab Figures releases 1:6th Scale Female Long Sleeve Faux Leather Jackets
  • SAREPTA ALERT: Bragar Eagel & Squire, P.C. is Investigating Sarepta Therapeutics, Inc. on Behalf of Sarepta Stockholders and Encourages Investors to Contact the Firm
  • Striction BP [[Update Mar2023!]]- Is It Safe? Must Read This
  • Genie Script: 20 Word Script by Wesley Virgin
  • BMI WINS MASSIVE VICTORY FOR SONGWRITERS, COMPOSERS & PUBLISHERS FOR LIVE CONCERT RATES
  • Sky Harbour Group Corporation Announces its 2022 Financial Results, Modification of SH Capital's 2021 Project Portfolio, Recapitalization of its Obligated Group, and Opening of its Campus at Miami-Opa Locka Executive Airport
  • Jake Paul Teams Up with The Berman Team, Sponsored by Berman Law Group for charity event supporting Boxing Bullies
  • Matt Fogelgren to Join Cleartelligence Executive Team as Chief Revenue Officer
  • ACI's Forum on FinTech & Emerging Payment Systems is back to New York City!
  • Keebos Unveils Keebos 2.0: The Ultimate Crossbody Phone Case
  • Kookalimba Launches K80M Loving Heart Mini Kalimba, the Perfect Musical Companion

Popular on Nyenta

  • New Rochelle: 2023 State of the City Address
  • New Rochelle: Registration Begins March 6 for Summer Day Camps
  • New Rochelle: Upcoming March events
  • New Rochelle: Registration Now Open for Girls on the Run
  • New Rochelle: City Launches New Special Needs Summer Employment Program
  • New Book - A Little Boy on Ramree Island By Aung Z. and Jill Mong
  • New Rochelle: Upcoming March events
  • Yonkers Mayor Spano & Yonkers Police Department Unveil Initiative to Combat Shoplifting at Local Retail Stores
  • Yonkers Police arrest three NYC men for property crimes; 17 suspected stolen catalytic converters discovered
  • New Rochelle: Armed Robbery – Liquor Store 558 North Ave

Similar on Nyenta

  • Top Causes of Car Accidents in NYC
  • Shima Capital's Founder Yida Gao Teaches Crypto Finance Course at MIT
  • Moore Kuehn Encourages DFFN, KMF, CSTI, and BGRY Investors to Contact Law Firm
  • Olga Torres Named Top Advisor by Foreign Investment Watch
  • ASI Hosts 2023 Executive Summit for Partners and Announces Annual Award Winners
  • Namify's Website Name Generator: The Ultimate Solution for Finding Your Perfect Website Name
  • New Report Reveals What Teen Girls Think About TikTok, Instagram, and the Impact That Social Media Has on Their Lives
  • TAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against TAL Education Group and Encourages Investors to Contact the Firm
  • Sherry Orel Joins STS Capital Partners
  • SAREPTA ALERT: Bragar Eagel & Squire, P.C. is Investigating Sarepta Therapeutics, Inc. on Behalf of Sarepta Stockholders and Encourages Investors to Contact the Firm
Copyright © 2023 nyenta.com | Terms of Service | Privacy Policy | Contribute | Contact Us